SCHEDULE: Guardian Pharmacy Services Stakeholder Filings

Multiple parties have filed an amendment to Schedule 13D, collectively reporting beneficial ownership of approximately 43.9% of Guardian Pharmacy Services, Inc. Class A common stock.

Summary

• This filing is an Amendment No. 4 to a Schedule 13D, updating previous filings by several reporting persons regarding their beneficial ownership of Guardian Pharmacy Services, Inc. Class A common stock.
• Collectively, the reporting persons beneficially own 27,822,550 shares of Class A common stock, representing approximately 43.9% of the outstanding shares.
• The percentage is calculated based on 63,320,300 shares outstanding as of September 27, 2026, as disclosed in a prior Form 8-K.
• A portion of the shares (13,521,396) were issued upon the automatic conversion of Class B common stock on September 27, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the nature of a Schedule 13D filing, which typically indicates a change in control or a significant stake acquisition, often leading to market uncertainty.

Negatives

• The filing is an amendment to a Schedule 13D, which indicates a significant change in beneficial ownership or a potential shift in control, often creating uncertainty for investors.

Risks

• The nature of a Schedule 13D filing suggests potential activist investor involvement or a move towards gaining control, which can lead to strategic shifts and operational changes that may not align with all stakeholders' interests.
• The aggregation of a significant stake (43.9%) by multiple reporting persons could signal a coordinated effort to influence company direction, potentially leading to governance disputes or strategic realignments.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance. It primarily focuses on reporting current beneficial ownership.

Management Comments

• William E. Bindley shares voting and investment power with Thomas J. Salentine, Jr. over an aggregate of 16,669,666 shares of Class A common stock currently owned by Bindley Capital Partners I, LLC by virtue of his position as member and officer of Bindley Capital Partners, LLC, the manager of Bindley Capital.
• Thomas J. Salentine, Jr. directly owns 35,714 shares of Class A common stock and also shares voting and investment power with William E. Bindley over an aggregate of 16,669,666 shares of Class A common stock currently owned by Bindley Capital by virtue of his position as member and officer of Bindley Capital Partners, LLC, the manager of Bindley Capital.
• John Ackerman has voting and investment power over an aggregate of 3,863,806 shares of Class A common stock currently owned by Pharmacy Investors, LLC by virtue of his position as Manager of Pharmacy Investors.
• Investment and voting decisions for the shares held by Cardinal Equity Fund, L.P. require unanimous consent of the investment committee of Cardinal Equity Partners, LLC, the general partner of Cardinal, which consists of John Ackerman, James L. Smeltzer, Peter J. Munson and Michael E. Smith. Therefore, no individual member of the investment committee is deemed to be the beneficial owner of the shares reported.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are common in industries undergoing consolidation or where significant investment funds seek to influence corporate strategy. Guardian Pharmacy Services operates in the pharmacy services sector, which has seen considerable M&A activity and strategic investment.

Related Party Transactions

• The filing references a Stockholders' Agreement dated September 25, 2024, by and among Guardian Pharmacy Services, Inc., Bindley Capital Partners I, LLC, Pharmacy Investors, LLC, Cardinal Equity Fund LP, Fred Burke, David Morris, and Kendall Forbes, indicating a structured relationship and potential agreements among these parties concerning the company's shares.

Stakeholder Impact

• Shareholders may experience increased volatility or uncertainty due to the significant collective stake and potential for coordinated action by the reporting persons.
• The company's strategic direction could be influenced by the objectives of these reporting persons, potentially impacting future operations and profitability.

Next Steps

• The reporting persons will continue to monitor the business and affairs of the Issuer.
• The reporting persons may engage in discussions with management, the board of directors, other shareholders, or other relevant parties concerning the Issuer's business, strategy, and prospects.
• The reporting persons may take such actions as they deem appropriate in light of their review of the foregoing, including, without limitation, acquiring additional securities of the Issuer, disposing of securities of the Issuer, or engaging in any other transaction involving the Issuer.

Key Dates

Recommendation

The filing indicates a significant collective ownership stake (43.9%) by multiple parties, suggesting potential for influence or a change in strategy. However, without specific details on the reporting persons' intentions or any immediate actions, a 'hold' recommendation is prudent to observe further developments.

Keywords

Guardian Pharmacy Services, Schedule 13D, Beneficial Ownership, Class A Common Stock, Bindley Capital Partners, Pharmacy Investors, Cardinal Equity Fund, Shareholder Activism